Evidence map›Paper›PMID 32919240›Full record

SynthesisClinical neurology and neurosurgery2020

Relationship between the history of cerebrovascular disease and mortality in COVID-19 patients: A systematic review and meta-analysis.

William Andrés Florez-Perdomo, Sergio Andrés Serrato-Vargas, Pilar Bosque-Varela, Luis Rafael Moscote-Salazar, Andrei F Joaquim, Amit Agrawal, Álvaro Ricardo Soto-Angel, Leidy Tatiana Tovar-Montenegro

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical neurology and neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

William Andrés Florez-PerdomoLatinamerican Council of Neurocritical Care, ClaNi, Colombia; Southcolombian University, Neiva-Huila, Colombia.
Sergio Andrés Serrato-VargasSouthcolombian University, Neiva-Huila, Colombia.
Pilar Bosque-VarelaParacelsus Medical University, Salzburg, Austria.
Luis Rafael Moscote-SalazarParacelsus Medical University, Salzburg, Austria. Electronic address: Rafaelmoscote21@gmail.coom.
Andrei F JoaquimDepartment of Neurosurgery, University of Campinas, Brazil.
Amit AgrawalDepartment of Neurosurgery, All India Institute of Medical Sciences, Saket Nagar, Bhopal, 462020, Madhya Pradesh, India.
Álvaro Ricardo Soto-AngelDepartment of Neurosurgery, UROS Clinic, Neiva-Huila, Colombia.
Leidy Tatiana Tovar-MontenegroSouthcolombian University, Neiva-Huila, Colombia.
South Colombian University · COParacelsus Medical University · ATAll India Institute of Medical Sciences Bhopal · INHospital Universitario de Neiva · COUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesPast history of stroke has been associated with an increased risk of a new ischemic stroke. Several studies have indicated increased prevalence of strokes among coronavirus patients. However, the role of past history of stroke in COVID19 patients is still unclear. The purpose of this systematic review is to evaluate and summarize the level of evidence on past history of stroke in COVID19 patients.

methodsA systematic review was performed according to the PRISMA guidelines was performed in PubMed, Embase, EBSCO Host, Scopus, Science Direct, Medline, and LILACS. Eligibility criteria: We evaluated studies including patients with diagnosis of COVID 19 and a past history of stroke. Risk of bias: was evaluated with the Newcastle- Ottawa Scale (NOS) and experimental studies were evaluated using the ROBINS-I scale.

resultsSeven articles out of the total 213 articles were evaluated and included, involving 3244 patients with SARS VOC 2 Disease (COVID19) of which 198 had a history of cerebrovascular disease. Meta-analysis of the data was performed, observing an increase in mortality in patients with a history of cerebrovascular disease compared to those with different comorbidities or those without underlying pathology (OR 2.78 95 % CI [1.42-5.46] p = 0.007; I

conclusionsThe history of cerebrovascular disease was associated with a 2.78-fold increased risk of mortality compared to patients with other comorbidities or without underlying pathologies.

Indexed as

BetacoronavirusBrain IschemiaCerebrovascular DisordersCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralRisk FactorsSARS-CoV-2Severity of Illness IndexStrokeCOVID-19MortalityStroke

Identifiers

PMID32919240
PMCPMC7446719
OpenAlexW3081039971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.